William J. Enright
2017
In 2017, William J. Enright earned a total compensation of $1M as Chief Executive Officer at PharmAthene, a 116% increase compared to previous year.
Compensation breakdown
| Bonus | $87,450 |
|---|---|
| Option Awards | $575,000 |
| Salary | $368,285 |
| Other | $14,399 |
| Total | $1,045,134 |
Enright received $575K in option awards, accounting for 55% of the total pay in 2017.
Enright also received $87.5K in bonus, $368.3K in salary and $14.4K in other compensation.
Rankings
In 2017, William J. Enright's compensation ranked 8,772nd out of 14,666 executives tracked by ExecPay. In other words, Enright earned more than 40.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,772 out of 14,666 | 40th |
Division Manufacturing | 3,346 out of 5,768 | 42nd |
Major group Chemicals And Allied Products | 1,131 out of 2,074 | 46th |
Industry group Drugs | 900 out of 1,730 | 48th |
Industry Pharmaceutical Preparations | 706 out of 1,329 | 47th |
Source: SEC filing on July 26, 2018.
Enright's colleagues
We found three more compensation records of executives who worked with William J. Enright at PharmAthene in 2017.